CONFIRM trial: what is the real efficacy of second-line immunotherapy in mesothelioma? - Authors' reply

Griffiths, Gareth (2022) CONFIRM trial: what is the real efficacy of second-line immunotherapy in mesothelioma? - Authors' reply. Lancet Oncology, 23 (1), e14-e15. (doi:10.1016/S1470-2045(21)00722-1).

Record type: Article

Text

lancetletterreply - Version of Record

Restricted to Repository staff only

Request a copy

More information

e-pub ahead of print date: 29 December 2021

Published date: January 2022

Identifiers

Local EPrints ID: 454129

URI: http://eprints.soton.ac.uk/id/eprint/454129

DOI: doi:10.1016/S1470-2045(21)00722-1

ISSN: 1470-2045

PURE UUID: 5cd6f2da-96a1-4aa7-8298-f4b14bdad4f4

ORCID for Gareth Griffiths:

orcid.org/0000-0002-9579-8021

Catalogue record

Date deposited: 01 Feb 2022 17:35

Last modified: 17 Mar 2024 03:36

Export record

Altmetrics

Share this record

Share this on Facebook Share this on Twitter Share this on Weibo

Contributors

Author: Gareth Griffiths

Download statistics

Downloads from ePrints over the past year. Other digital versions may also be available to download e.g. from the publisher's website.

View more statistics

Library staff additional information

Atom RSS 1.0 RSS 2.0

Contact ePrints Soton: eprints@soton.ac.uk

ePrints Soton supports OAI 2.0 with a base URL of http://eprints.soton.ac.uk/cgi/oai2

This repository has been built using EPrints software, developed at the University of Southampton, but available to everyone to use.